Carboxymethylcellulose Completed Phase 4 Trials for Dry Eye Syndrome (DES) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02758327Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops
NCT05292755Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome
NCT03380624Tear Lipid Layer Thickness With Emollient Eye Drops
NCT02121847Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
NCT02014922A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
NCT01280110The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients
NCT00938704Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00761202Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
NCT00756678Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00386646Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye